News

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...
The patient voice has grown in importance, and now it is being applied to develop and deliver more sophisticated drug delivery ... with the patients, and test the device with the patients ...
Burke and colleagues reported the safety and efficacy of S-ICDs in a pooled analysis of two prospective ... many advances have been made in drug, ablation, and device therapy for cardiac ...
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.
The blood test is used to detect abnormal protein deposits in the brain that are associated with Alzheimer's. The test is for people 55 and older who are already showing signs of the disease, ...
Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...
The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...
Analog Devices, Inc. engages in the design, manufacture, testing, and marketing of integrated circuits (ICs), software, and subsystems products in the United States, rest of North and South ...
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help ...
Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. It operates through four segments: Data Center, Client, Gaming, and Embedded. The company offers artificial intelligence ...